Global Typhoid Vi Polysaccharide Vaccine  Market Report 2024

Typhoid Vi Polysaccharide Vaccine Global Market Report 2024 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Typhoid Vi Polysaccharide Vaccine Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Typhoid Vi Polysaccharide Vaccine Market Definition And Segments

Typhoid Vi polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi.

The main types of typhoid Vi polysaccharide vaccine are child and adult. A child is a person between birth and puberty, or full growth. The routes of administration for this vaccine include oral and parenteral and are applied in government institutions, the private sector, and others.

The typhoid vi polysaccharide vaccine market covered in this report is segmented –

1) By Type: Child, Adult

2) By Route of Administration: Oral, Parenteral

3) By Application: Government Institution, Private Sector, Other Applications

The typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from $4.98 billion in 2023 to $5.84 billion in 2024 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to disease prevalence, global health initiatives, traveler vaccination, government immunization efforts, vaccine efficacy and safety.

The typhoid vi polysaccharide vaccine market size is expected to see rapid growth in the next few years. It will grow to $11.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to expanded immunization programs, global health policy focus, epidemiological surveillance, rising demand in travel medicine, environmental and social factors. Major trends in the forecast period include R&D investments, regulatory support, epidemiological studies, public health awareness.

Escalating Typhoid Prevalence Fuels Expansion In The Typhoid Vi Polysaccharide Vaccine Market

Rising typhoid prevalence is expected to propel the growth of the typhoid VI polysaccharide vaccine market going forward. Typhoid is an infection caused by the bacteria Salmonella typhi that can be fatal. It usually spreads through contaminated food or drink. Typhoid Vi polysaccharide vaccine is used to immunize adults and children aged 2 and up against typhoid fever caused by Salmonella enterica serovar Typhi, S. Typhi. For instance, in March 2021, according to a report shared by the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, infections with Salmonella Typhi were believed to affect 5,700 Americans annually, with 620 of these likely to require hospitalization. Typhoid fever mostly causes between 11 and 21 million cases worldwide every year, along with 200,000 fatalities. Therefore, the rising typhoid prevalence is driving the growth of the typhoid Vi polysaccharide vaccine market.

Strategic Impact Of Growing Immunization Campaigns On The Typhoid Vi Polysaccharide Vaccine Market

Growing immunization campaigns is expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Immunization campaigns refer to delivery strategy used to quickly reach large numbers of individuals with one or more vaccines, typically conducted at the national or sub-national level . Immunization campaigns are essential for the effective deployment and utilization of the typhoid Vi Polysaccharide Vaccine, especially in regions where typhoid fever poses a significant public health challenge. For instance, in April 2022, with support from Gavi, the Vaccine Alliance, a public–private global health partnership, World Health Organization, a Switzerland-based intergovernmental organization, United Nations International Children's Emergency Fund, a US-based Humanitarian aid organization and other partners, the Government of Nepal launched a new vaccine campaign introducing Typhoid Conjugate Vaccine (TCV) into the routine immunization program across the country. The 3-week campaign, which will run from 8th April to 1st May 2022, aims to reach all children between 15 months and 15 years to quickly achieve wider protection from typhoid, increase the impact of the vaccine introduction and combat the rise of antimicrobial resistance. Over 50,000 vaccination sites have been established across rural and urban settings in the country, including schools. Therefore, growing immunization campaigns is driving the growth of the typhoid Vi polysaccharide vaccine market.

Healthcare Expenditure Surge Fuels Growth In The Typhoid VI Polysaccharide Vaccine Market

Growing expenditure in the healthcare sector is expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure helps typhoid Vi polysaccharide vaccine manufacturers develop more typhoid vaccines, which increase the demand for the typhoid Vi polysaccharide vaccine market. For instance, according to the National Health Expenditure Projections 2018-2027, a US-based national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Therefore, growing expenditure in the healthcare sector is driving the growth of the typhoid Vi polysaccharide vaccine market.

Major companies operating in the typhoid vi polysaccharide vaccine market report are Sanofi Pasteur SA, GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan NV, Serum Institute of India Pvt. Ltd., Biological E. Limited, Panacea Biotec Ltd., Shantha Biotechnics Pvt. Ltd., Cadila Healthcare Ltd., Merck Sharp & Dohme Corp., AstraZeneca Limited, Boryung Pharmaceutical Co., Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited

International Vaccine Institute's Dynamic Partnerships With Moderna And GSK Fuel Advances In Typhoid Vi Polysaccharide Vaccine Market

Strategic partnerships are a key trend gaining popularity in the typhoid Vi polysaccharide vaccine market. Major companies operating in the typhoid Vi polysaccharide vaccine market are entering into partnerships to strengthen their position in the typhoid Vi polysaccharide market. For instance, in July 2022, The International Vaccine Institute, a South Korea-based international organization focused on infectious diseases of global health importance such as cholera, typhoid, shigella, and salmonella, partnered with Moderna, a US-based biopharmaceutical company. This partnership led to the world’s first affordable oral cholera vaccine and a new-generation typhoid conjugate vaccine.

Innovative Collaborations And Strategic Investments In Typhoid Vi Polysaccharide Vaccine Development

Major companies operating in the typhoid Vi polysaccharide vaccine market are focusing on investments to sustain their position in the market. Investments in the development and distribution of the typhoid Vi polysaccharide vaccine have been substantial, reflecting the importance of preventing and controlling typhoid fever. For instance, in August 2023, SK Bioscience, a South Korea-based biotech company, and Vaxxas, an Australia-based biotechnology company that develops a novel needle-free vaccination technology, secured AUD5.4 million ($3.67 million) in funding from Wellcome, a UK-based charity, to develop a typhoid conjugate vaccine that can be delivered by a needle-free patch. This collaboration aims to revolutionize vaccine delivery by developing a novel vaccine-delivery device combination product using Vaxxas' high-density microarray patch (HD-MAP) platform technology with SK Bioscience's proprietary typhoid vaccine.

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2023. The regions covered in the typhoid vi polysaccharide vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the typhoid vi polysaccharide vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The typhoid Vi polysaccharide vaccine market consists of sales of Vi capsular polysaccharide vaccine, and non-conjugated Vi polysaccharide vaccine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The typhoid Vi polysaccharide vaccine market research report is one of a series of new reports from The Business Research Company that provides typhoid Vi polysaccharide vaccine market statistics, including typhoid Vi polysaccharide vaccine industry global market size, regional shares, competitors with typhoid Vi polysaccharide vaccine market share, detailed typhoid Vi polysaccharide vaccine market segments, market trends and opportunities, and any further data you may need to thrive in typhoid Vi polysaccharide vaccine industry. This Typhoid Vi polysaccharide vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Typhoid Vi Polysaccharide Vaccine Market Characteristics

    3. Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies

    4. Typhoid Vi Polysaccharide Vaccine Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Typhoid Vi Polysaccharide Vaccine Market Size and Growth

    5.1. Global Typhoid Vi Polysaccharide Vaccine Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Typhoid Vi Polysaccharide Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Typhoid Vi Polysaccharide Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Typhoid Vi Polysaccharide Vaccine Market Segmentation

    6.1. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Child

    Adult

    6.2. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    6.3. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Government Institution

    Private Sector

    Other Applications  

    7. Typhoid Vi Polysaccharide Vaccine Market Regional And Country Analysis

    7.1. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market  

    8.1. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Typhoid Vi Polysaccharide Vaccine Market  

    9.1. China Typhoid Vi Polysaccharide Vaccine Market Overview  

    9.2. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Typhoid Vi Polysaccharide Vaccine Market  

    10.1. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Typhoid Vi Polysaccharide Vaccine Market  

    11.1. Japan Typhoid Vi Polysaccharide Vaccine Market Overview  

    11.2. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Typhoid Vi Polysaccharide Vaccine Market  

    12.1. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Typhoid Vi Polysaccharide Vaccine Market  

    13.1. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Typhoid Vi Polysaccharide Vaccine Market  

    14.1. South Korea Typhoid Vi Polysaccharide Vaccine Market Overview  

    14.2. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Typhoid Vi Polysaccharide Vaccine Market  

    15.1. Western Europe Typhoid Vi Polysaccharide Vaccine Market Overview

    15.2. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Typhoid Vi Polysaccharide Vaccine Market  

    16.1. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Typhoid Vi Polysaccharide Vaccine Market  

    17.1. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Typhoid Vi Polysaccharide Vaccine Market  

    18.5. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Typhoid Vi Polysaccharide Vaccine Market  

    19.9. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Typhoid Vi Polysaccharide Vaccine Market  

    20.13. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market  

    21.1. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market Overview

    21.2. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Typhoid Vi Polysaccharide Vaccine Market  

    22.1. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Typhoid Vi Polysaccharide Vaccine Market  

    23.1. North America Typhoid Vi Polysaccharide Vaccine Market Overview

    23.2. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Typhoid Vi Polysaccharide Vaccine Market  

    24.1. USA Typhoid Vi Polysaccharide Vaccine Market Overview

    24.2. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Typhoid Vi Polysaccharide Vaccine Market  

    25.1. Canada Typhoid Vi Polysaccharide Vaccine Market Overview

    25.2. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Typhoid Vi Polysaccharide Vaccine Market  

    26.1. South America Typhoid Vi Polysaccharide Vaccine Market Overview

    26.2. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Typhoid Vi Polysaccharide Vaccine Market  

    27.1. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Typhoid Vi Polysaccharide Vaccine Market  

    28.1. Middle East Typhoid Vi Polysaccharide Vaccine Market Overview

    28.2. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Typhoid Vi Polysaccharide Vaccine Market  

    29.1. Africa Typhoid Vi Polysaccharide Vaccine Market Overview

    29.2. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Company Profiles

    30.1. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape

    30.2. Typhoid Vi Polysaccharide Vaccine Market Company Profiles

    30.2.1. Sanofi Pasteur SA

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. GlaxoSmithKline plc

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co. Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Pfizer Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Johnson & Johnson Private Limited

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Benchmarking

    32. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Typhoid Vi Polysaccharide Vaccine Market

    34. Typhoid Vi Polysaccharide Vaccine Market Future Outlook and Potential Analysis

    34.1 Typhoid Vi Polysaccharide Vaccine Market In 2028 - Countries Offering Most New Opportunities

    34.2 Typhoid Vi Polysaccharide Vaccine Market In 2028 - Segments Offering Most New Opportunities

    34.3 Typhoid Vi Polysaccharide Vaccine Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Sanofi Pasteur SA Financial Performance
  • Table 75: GlaxoSmithKline plc Financial Performance
  • Table 76: Merck & Co. Inc. Financial Performance
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Johnson & Johnson Private Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Sanofi Pasteur SA Financial Performance
  • Figure 75: GlaxoSmithKline plc Financial Performance
  • Figure 76: Merck & Co. Inc. Financial Performance
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Johnson & Johnson Private Limited Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the typhoid Vi polysaccharide vaccine market?

typhoid Vi polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

How will the typhoid Vi polysaccharide vaccine market drivers and restraints affect the typhoid Vi polysaccharide vaccine market dynamics? What forces will shape the typhoid Vi polysaccharide vaccine industry going forward?

The typhoid Vi polysaccharide vaccine market major growth driver - escalating typhoid prevalence fuels expansion in the typhoid Vi polysaccharide vaccine market. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

What is the forecast market size or the forecast market value of the typhoid Vi polysaccharide vaccine market ?

The typhoid Vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from $4.98 billion in 2023 to $5.84 billion in 2024 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to disease prevalence, global health initiatives, traveler vaccination, government immunization efforts, vaccine efficacy and safety. The typhoid Vi polysaccharide vaccine market size is expected to see rapid growth in the next few years. It will grow to $11.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to expanded immunization programs, global health policy focus, epidemiological surveillance, rising demand in travel medicine, environmental and social factors. Major trends in the forecast period include r&d investments, regulatory support, epidemiological studies, public health awareness. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

How is the typhoid Vi polysaccharide vaccine market segmented?

The typhoid Vi polysaccharide vaccine market is segmentedThe typhoid Vi polysaccharide vaccine market covered in this report is segmented –
1) By Type: Child, Adult
2) By Route of Administration: Oral, Parenteral
3) By Application: Government Institution, Private Sector, Other Applications For further insights on the typhoid Vi polysaccharide vaccine market,
request a sample here

Which region has the largest share of the typhoid Vi polysaccharide vaccine market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2023. The regions covered in the typhoid Vi polysaccharide vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here.

Who are the major players in the typhoid Vi polysaccharide vaccine market?

Major companies operating in the typhoid Vi polysaccharide vaccine market report are Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan NV, Serum Institute of India Pvt. Ltd., Biological E. Limited, Panacea Biotec Ltd., Shantha Biotechnics Pvt. Ltd., Cadila Healthcare Ltd., Merck Sharp & Dohme Corp., AstraZeneca Limited, Boryung Pharmaceutical Co., Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here.

What are the key trends in the typhoid Vi polysaccharide vaccine market?

Major trend in the typhoid Vi polysaccharide vaccine market - international vaccine institute's dynamic partnerships with moderna and gsk fuel advances in typhoid Vi polysaccharide vaccine market. For further insights on the typhoid Vi polysaccharide vacc request a sample here.

What are the major opportunities in the typhoid Vi polysaccharide vaccine market? What are the strategies for the typhoid Vi polysaccharide vaccine market?

For detailed insights on the major opportunities and strategies in the typhoid Vi polysaccharide vaccine market, request a sample here.

How does the typhoid Vi polysaccharide vaccine market relate to the overall economy and other similar markets?

For detailed insights on typhoid Vi polysaccharide vaccine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the typhoid Vi polysaccharide vaccine industry?

For detailed insights on the mergers and acquisitions in the typhoid Vi polysaccharide vaccine industry, request a sample here.

What are the key dynamics influencing the typhoid Vi polysaccharide vaccine market growth? SWOT analysis of the typhoid Vi polysaccharide vaccine market.

For detailed insights on the key dynamics influencing the typhoid Vi polysaccharide vaccine market growth and SWOT analysis of the typhoid Vi polysaccharide vaccine industry, request a sample here.